Amino-Terminal Pro-B-Type Natriuretic Peptide in Refractory Kawasaki Disease

被引:0
|
作者
Fernando Maria de Benedictis
Massimo Colaneri
Patrizia Osimani
Maria Grazia Bettuzzi
机构
[1] Salesi Children’s Hospital,Department of Pediatrics
[2] Azienda Ospedaliero-Universitaria Ospedali Riuniti,Department of Cardiovascular Medicine
[3] Azienda Ospedaliero-Universitaria Ospedali Riuniti,undefined
来源
Pediatric Cardiology | 2009年 / 30卷
关键词
Cardiac biomarkers; Infliximab;
D O I
暂无
中图分类号
学科分类号
摘要
Serum concentrations of brain natriuretic peptide and its amino-terminal cleavage pro-fragment, NT-proBNP, have never been reported in refractory Kawasaki disease. Changes in NT-proBNP levels after infliximab treatment in an infant with severe cardiovascular complications are reported here. The regular evaluation of this cardiac biomarker after infliximab treatment may have clinical relevance in patients with refractory Kawasaki disease and severe heart involvement.
引用
收藏
相关论文
共 50 条
  • [21] New Kid on the Block? Is Amino-Terminal Pro-B-Type Natriuretic Peptide Ready for the Big Time?
    Ruth, Amanda
    Akcan-Arikan, Ayse
    PEDIATRIC CRITICAL CARE MEDICINE, 2019, 20 (02) : 201 - 202
  • [22] Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community - Determinants and detection of left ventricular dysfunction
    Costello-Boerrigter, LC
    Boerrigter, G
    Redfield, MM
    Rodeheffer, RJ
    Urban, LH
    Mahoney, DW
    Jacobsen, SJ
    Heublein, DM
    Burnett, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (02) : 345 - 353
  • [23] Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients
    Wang, Yunhong
    Zhang, Rongcheng
    Huang, Yan
    Zhai, Mei
    Zhou, Qiong
    An, Tao
    Huang, Yuhui
    Zhao, Xuemei
    Tian, Pengchao
    Zhang, Yuhui
    Zhang, Jian
    CLINICA CHIMICA ACTA, 2019, 491 : 8 - 14
  • [24] Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons
    Campbell, D. J.
    Woodward, M.
    Chalmers, J.
    Colman, S.
    Jenkins, A. J.
    Neal, B.
    Patel, A.
    MacMahon, S.
    EUROPEAN HEART JOURNAL, 2005, 26 : 257 - 257
  • [25] Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure
    Araujo, Jose Paulo
    Azevedo, Ana
    Lourenco, Patricia
    Rocha-Goncalves, Francisco
    Ferreira, Antonio
    Bettencourt, Paulo
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (09): : 1248 - 1250
  • [26] Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide
    Abhayaratna, Walter P.
    Marwick, Thomas H.
    Becker, Niels G.
    Jeffery, Ian M.
    McGill, Darryl A.
    Smith, Wayne T.
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 941 - 948
  • [27] B-type natriuretic peptide or amino-terminal pro-B-type natriuretic peptide-guided treatment of heart failure: what is the next STEP?
    Troughton, Richard W.
    Nicholls, M. Gary
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (10) : 1046 - 1048
  • [28] Amino-terminal pro-B-type natriuretic peptides and prognosis in chronic heart failure
    Masson, Serge
    Latini, Roberto
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (3A): : 56A - 60A
  • [29] Comparison of Copeptin, b-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease
    Neuhold, S.
    Huelsmann, M.
    Strunk, G.
    Stoiser, B.
    Struck, J.
    Morgenthaler, N.
    Bergmann, A.
    Gouya, G.
    Elhenicky, M.
    Pacher, R.
    EUROPEAN HEART JOURNAL, 2008, 29 : 178 - 179
  • [30] Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms
    Januzzi, James L., Jr.
    Chen-Tournoux, Annabel A.
    Moe, Gordon
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (3A): : 29A - 38A